Results of intracellular cytokine analysis
Variable . | Baseline . | 3 mo . | 6 mo . | 12 mo . | Controls, N = 30 . | ||
---|---|---|---|---|---|---|---|
ITP all pts, N = 30 . | ITP all pts, N = 30 . | Responders, N = 14 . | Nonresponders, N = 16 . | Responders, N = 14 . | Responders, N = 9 . | ||
Th1, × 109/L | 0.23 ± 0.10 | 0.24 ± 0.13 | 0.24 ± 0.14 | 0.24 ± 0.13 | 0.24 ± 0.14 | 0.22 ± 0.12 | 0.25 ± 0.08 |
Th1, % | 16.3 ± 5.3 | 15.2 ± 6.1 | 14.6 ± 5.3 | 15.8 ± 6.9 | 15.7 ± 6.8 | 15.3 ± 6.4 | 15.9 ± 2.6 |
Th2, × 109/L | 0.018 ± 0.008 | 0.29 ± 0.017* | 0.038 ± 0.017* | 0.021 ± 0.011 | 0.039 ± 0.018* | 0.032 ± 0.015* | 0.035 ± 0.013* |
Th2, % | 1.4 ± 0.6 | 1.9 ± 0.9* | 2.5 ± 0.9* | 1.3 ± 0.6 | 2.6 ± 1.0* | 2.4 ± 0.8* | 2.3 ± 0.5* |
Th1/Th2 | 19.1 ± 13.5 | 13.3 ± 6.4 | 10.9 ± 9.8* | 15.9 ± 13.6 | 7.1 ± 5.8* | 8.2 ± 3.6* | 7.5 ± 2.1* |
Tc1, × 109/L | 0.38 ± 0.17 | 0.33 ± 0.11 | 0.32 ± 0.11 | 0.33 ± 0.11 | 0.29 ± 0.10 | 0.32 ± 0.12 | 0.36 ± 0.11 |
Tc1, % | 26.2 ± 7.4 | 21.2 ± 3.8 | 20.4 ± 3.9 | 21.8 ± 3.7 | 19.1 ± 4.1 | 22.4 ± 3.3 | 23.4 ± 3.0 |
Tc2, × 109/L | 0.011 ± 0.004 | 0.021 ± 0.011* | 0.025 ± 0.012* | 0.017 ± 0.007 | 0.030 ± 0.12* | 0.028 ± 0.010* | 0.034 ± 0.013* |
Tc2, % | 0.8 ± 0.3 | 1.4 ± 0.6* | 1.6 ± 0.6* | 1.1 ± 0.4 | 2.0 ± 0.4* | 1.9 ± 0.5* | 2.2 ± 0.6* |
Tc1/Tc2 | 34.0 ± 14.2 | 18.4 ± 8.4* | 15.1 ± 8.1* | 21.3 ± 7.8* | 10.0 ± 2.8* | 11.8 ± 0.7* | 11.0 ± 2.7* |
Variable . | Baseline . | 3 mo . | 6 mo . | 12 mo . | Controls, N = 30 . | ||
---|---|---|---|---|---|---|---|
ITP all pts, N = 30 . | ITP all pts, N = 30 . | Responders, N = 14 . | Nonresponders, N = 16 . | Responders, N = 14 . | Responders, N = 9 . | ||
Th1, × 109/L | 0.23 ± 0.10 | 0.24 ± 0.13 | 0.24 ± 0.14 | 0.24 ± 0.13 | 0.24 ± 0.14 | 0.22 ± 0.12 | 0.25 ± 0.08 |
Th1, % | 16.3 ± 5.3 | 15.2 ± 6.1 | 14.6 ± 5.3 | 15.8 ± 6.9 | 15.7 ± 6.8 | 15.3 ± 6.4 | 15.9 ± 2.6 |
Th2, × 109/L | 0.018 ± 0.008 | 0.29 ± 0.017* | 0.038 ± 0.017* | 0.021 ± 0.011 | 0.039 ± 0.018* | 0.032 ± 0.015* | 0.035 ± 0.013* |
Th2, % | 1.4 ± 0.6 | 1.9 ± 0.9* | 2.5 ± 0.9* | 1.3 ± 0.6 | 2.6 ± 1.0* | 2.4 ± 0.8* | 2.3 ± 0.5* |
Th1/Th2 | 19.1 ± 13.5 | 13.3 ± 6.4 | 10.9 ± 9.8* | 15.9 ± 13.6 | 7.1 ± 5.8* | 8.2 ± 3.6* | 7.5 ± 2.1* |
Tc1, × 109/L | 0.38 ± 0.17 | 0.33 ± 0.11 | 0.32 ± 0.11 | 0.33 ± 0.11 | 0.29 ± 0.10 | 0.32 ± 0.12 | 0.36 ± 0.11 |
Tc1, % | 26.2 ± 7.4 | 21.2 ± 3.8 | 20.4 ± 3.9 | 21.8 ± 3.7 | 19.1 ± 4.1 | 22.4 ± 3.3 | 23.4 ± 3.0 |
Tc2, × 109/L | 0.011 ± 0.004 | 0.021 ± 0.011* | 0.025 ± 0.012* | 0.017 ± 0.007 | 0.030 ± 0.12* | 0.028 ± 0.010* | 0.034 ± 0.013* |
Tc2, % | 0.8 ± 0.3 | 1.4 ± 0.6* | 1.6 ± 0.6* | 1.1 ± 0.4 | 2.0 ± 0.4* | 1.9 ± 0.5* | 2.2 ± 0.6* |
Tc1/Tc2 | 34.0 ± 14.2 | 18.4 ± 8.4* | 15.1 ± 8.1* | 21.3 ± 7.8* | 10.0 ± 2.8* | 11.8 ± 0.7* | 11.0 ± 2.7* |
T-cell subset values are expressed as both absolute concentrations (× 109/L) and as percentage of CD3+ cells (%). Data are shown as mean plus or minus a standard deviation.
Statistically significant (P < .05) difference compared with baseline.